Page last updated: 2024-12-05

elemene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

elemene: a sclerosing and antineoplastic agent isolated from Curcuma wenyujin & Rhizoma zedoariae; beta- and delta- elemene are also available [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Curcuma wenyujinspecies[no description available]ZingiberaceaeA plant family of the order Zingiberales, subclass Zingiberidae, class Liliopsida. It includes plants which have both flavoring and medicinal properties such as GINGER; turmeric (CURCUMA), and cardamom (ELETTARIA).[MeSH]

Cross-References

ID SourceID
PubMed CID10583
MeSH IDM0116838

Synonyms (21)

Synonym
elemene
(-)-cis-beta-elemene
1-methyl-1-vinyl-2,4-diisopropenyl-cyclohexane
1-ethenyl-1-methyl-2,4-bis(prop-1-en-2-yl)cyclohexane
33880-83-0
einecs 251-713-0
(- )-bete-elemene
cyclohexane, 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-, (1r,2r,4s)-rel-
(1alpha,2beta,4beta)-1-methyl-2,4-bis(methylvinyl)-1-vinylcyclohexane
cyclohexane, 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-, (1alpha,2beta,4beta)-
cyclohexane, 1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)-
2,4-diisopropenyl-1-methyl-1-vinylcyclohexane #
OPFTUNCRGUEPRZ-UHFFFAOYSA-N
2,4-diisopropenyl-1-me-thyl-1-vinyl-cyclohexane
110823-68-2
BCP31326
?-elemene
(+/-)-beta-elemene
EN300-296339
1-ethenyl-1-methyl-2,4-bis(1-methylethenyl)cyclohexane
DTXSID801034870

Research Excerpts

Overview

Elemene (ELE) is a group of broad-spectrum anticancer active ingredients with low toxicity extracted from traditional Chinese medicines. Elemene is a natural compound extracted from Zingiberaceae plants, and is used in various cancer.

ExcerptReferenceRelevance
"Elemene (ELE) is a group of broad-spectrum anticancer active ingredients with low toxicity extracted from traditional Chinese medicines (TCMs), such as Curcumae Rhizoma and Curcuma Radix, which can exert antitumour activities by regulating various signal pathways and targets. "( Targeted drug delivery systems for elemene in cancer therapy: The story thus far.
Qi, QR; Tian, H; Yue, BS; Zhai, BT; Zhao, F, 2023
)
2.63
"Elemene is a natural compound extracted from Zingiberaceae plants, and is used in various cancer. "( Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.
Chen, B; Chen, L; Chen, X; Duan, T; Feng, J; Huang, X; Jin, T; Lin, S; Liu, S; Liu, Y; Pan, T; Sui, X; Xiang, Y; Xie, T; Yan, L; Zhang, M; Zhang, R; Zhang, W, 2020
)
2.31
"Elemene is a natural plant compound extracted from the medicinal Chinese herb, Rhizomazedoariae, which has been employed as an antitumor agent for the treatment of a number of tumors, including osteosarcoma."( Elemene inhibits osteosarcoma growth by suppressing the renin‑angiotensin system signaling pathway.
Chen, J; Ding, L; Hou, Y; Yin, Y; Zhang, G, 2018
)
2.64
"β-elemene is a noncytotoxic Class II antitumor drug extracted from the traditional Chinese medicine "( Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy.
Chen, X; Li, C; Sui, X; Wang, S; Xie, T; You, Y; Zeng, Y; Zeng, Z; Zhai, B; Zhang, N, 2018
)
1.5
"Elemene is an effective anticancer component extracted from Zingiberaceae plants. "( Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
Hui, L; Liu, Z; Long, J, 2019
)
2.22
"β-elemene is a natural antitumor drug from plants."( β-elemene reverses chemoresistance of breast cancer via regulating MDR-related microRNA expression.
Chen, L; Chen, W; Mao, Cf; Sun, DW; Tang, JH; Wu, JZ; Zhang, Hd; Zhang, J; Zhao, JH; Zhong, SL, 2014
)
1.68
"Elemene is a chemical extracted from plants. "( An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas.
Fan, HZ; Huang-Fu, HJ; Lin, J; Ni, LF; Wu, XS; Xie, T; Yan, HF, 2009
)
2.07
"Elemene is a broad-spectrum antitumor agent. "( Lysosomal membrane permeabilization contributes to elemene emulsion-induced apoptosis in A549 cells.
Geng, CY; Jiang, LP; Li, LJ; Qu, Y; Shao, J; Wang, Q; Xu, YH; Zhong, LF; Zhu, TZ; Zou, LJ, 2011
)
2.06
"Elemene is an effective and safe treatment for patients with chylothorax."( Treatment of chylothorax with elemene.
Donglei, L; Jia, Z; Jianjun, Q; Song, Z; Yin, L, 2008
)
2.08

Effects

Elemene has dual effects on the survival rate of normal HUVECs in vitro, which is related to the concentration and the duration of drug exposure. It has significant effect on treatment of malignant brain tumor.

ExcerptReferenceRelevance
"Elemene has significant apoptosis promoting and Caspase-3 protein expression inducing effect on C6 glioma cells, which could be facilitated by nano-liposome bearing."( [Effect of nano-liposome sustained elemene in inducing cell apoptosis of C6 glioma].
Hu, J; Xu, DH, 2008
)
2.07
"Elemene has dual effects on the survival rate of normal HUVECs in vitro, which is related to the concentration and the duration of drug exposure. "( [The protection of elemene on injured HUVECs induced by hydrogen peroxide].
Tang, ST; Wang, GX; Wu, LY; Yin, TY, 2007
)
2.11
"Elemene has significant effect on treatment of malignant brain tumor. "( [Clinical study on treatment of 40 cases of malignant brain tumor by elemene emulsion injection].
Cai, W; Tan, P; Zhong, W, 2000
)
1.98

Actions

Elemene could inhibit the subcutaneous plantation of human laryngeal carcinoma in nude mice. Its mechanism may be associated with inhibited expression of VEGF-C and VEGFR-3.

ExcerptReferenceRelevance
"Elemene could inhibit the tumor growth in vivo. "( [Inhibition of eIF families expression and angiogenesis for human laryngeal carcinoma by elemene administration].
Tao, L; Yao, M; Zheng, LY; Zhou, L, 2005
)
1.99
"Elemene could inhibit the subcutaneous plantation of human laryngeal carcinoma in nude mice and its mechanism may be associated with inhibited expression of eIF families and angiogenesis factors. "( [Inhibition of eIF families expression and angiogenesis for human laryngeal carcinoma by elemene administration].
Tao, L; Yao, M; Zheng, LY; Zhou, L, 2005
)
1.99
"Elemene could inhibit the tumor growth in vivo. "( [Elemene in the treatment of the transplantable model of human laryngeal squamous carcinoma in nude mice].
Cao, Z; Ji, W, 2007
)
2.69
"Elemene could inhibit the subcutaneous plantation of human laryngeal carcinoma in nude mice and its mechanism may be associated with inhibited expression of VEGF-C and VEGFR-3."( [Elemene in the treatment of the transplantable model of human laryngeal squamous carcinoma in nude mice].
Cao, Z; Ji, W, 2007
)
2.69

Toxicity

ExcerptReferenceRelevance
" The primary clinical outcome was overall response rate (ORR); the secondary outcomes were quality of life (QOL) and adverse events (AEs)."( Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.
Chen, B; Chen, L; Chen, X; Duan, T; Feng, J; Huang, X; Jin, T; Lin, S; Liu, S; Liu, Y; Pan, T; Sui, X; Xiang, Y; Xie, T; Yan, L; Zhang, M; Zhang, R; Zhang, W, 2020
)
0.87

Compound-Compound Interactions

Elemene combined with chemotherapy in the treatment of GC may increase the efficiency of ORR. Network-based positive psychological nursing model combined with elemene injection is a reliable method to enhance the immune function and QOL of LC patients.

ExcerptReferenceRelevance
" The findings were included into randomized controlled trials (RCTs) of elemene injection combined with cisplatin chemotherapeuties in treating small cell lung cancer (NSCLC)."( [Meta-analysis on elemene injection combined with cisplatin chemotherapeutics in treatment of non-small cell lung cancer].
Hu, WH; Wang, XK; Xu, XW; Yuan, ZZ, 2013
)
0.96
" However, the efficacy and safety elemene combined with chemotherapy in advanced gastric cancer (GC) are lack of systematic assessment."( Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.
Chen, B; Chen, L; Chen, X; Duan, T; Feng, J; Huang, X; Jin, T; Lin, S; Liu, S; Liu, Y; Pan, T; Sui, X; Xiang, Y; Xie, T; Yan, L; Zhang, M; Zhang, R; Zhang, W, 2020
)
1.15
"To investigate the therapeutic effect of Elemene combined with Nedaplatin (ECN) on malignant pleural effusion (MPE) and its adverse reactions."( Effects of intracavitary administration of elemene combined with nedaplatin on malignant pleural effusion.
Chen, KH; Chen, R; Ning, Z; Ou, XM; Yang, YS; Yu, HY; Zhang, CY, 2022
)
1.25
"To explore the effect of the network-based positive psychological nursing model combined with elemene injection on negative emotions, immune function and quality of life (QOL) in patients with lung cancer (LC) undergoing chemotherapy."( Effect of Network-Based Positive Psychological Nursing Model Combined With Elemene Injection on Negative Emotions, Immune Function and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy in the Era of Big Data.
Li, Z; Sun, Y; Yang, S; Zheng, L, 2022
)
1.17
" The patients in CG received routine nursing intervention during chemotherapy, while those in EG received the network-based positive psychological nursing model combined with elemene injection to compare negative emotions, immune function and quality of life (QOL) between the two groups."( Effect of Network-Based Positive Psychological Nursing Model Combined With Elemene Injection on Negative Emotions, Immune Function and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy in the Era of Big Data.
Li, Z; Sun, Y; Yang, S; Zheng, L, 2022
)
1.14
"The network-based positive psychological nursing model combined with elemene injection is a reliable method to enhance the immune function and QOL of LC patients undergoing chemotherapy and alleviate their negative emotions, which has a high clinical application value."( Effect of Network-Based Positive Psychological Nursing Model Combined With Elemene Injection on Negative Emotions, Immune Function and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy in the Era of Big Data.
Li, Z; Sun, Y; Yang, S; Zheng, L, 2022
)
1.19

Bioavailability

ExcerptReferenceRelevance
"The objective was to develop an elemene oil/water (o/w) microemulsion and evaluate its characteristics and oral relative bioavailability in rats."( Preparation, characterization and relative bioavailability of oral elemene o/w microemulsion.
Huang, EZ; Li, H; Liu, J; Pei, X; Wang, A; Wang, S; Wang, X; Xie, T; Zeng, Z; Zhan, X; Zhou, G, 2010
)
0.88
" However, studies have indicated that turmeric oil, present in turmeric, can enhance the bioavailability of curcumin."( Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.
Aggarwal, BB; Gupta, SC; Li, S; Yuan, W, 2013
)
0.39
" Like curcuminoids, limited solubility and bioavailability are the most fragile domain, which circumscribe further applications of these compounds."( Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations.
Amalraj, A; Gopi, S; Jacob, J; Kunnumakkara, AB; Nair, A, 2019
)
0.51
" However, the strong hydrophobicity, short half-life, low bioavailability and weak in vivo targeting ability of ELE restrict its use."( Targeted drug delivery systems for elemene in cancer therapy: The story thus far.
Qi, QR; Tian, H; Yue, BS; Zhai, BT; Zhao, F, 2023
)
1.19

Dosage Studied

The in vivo BxPC-3 xenografts study exhibited that elemene was significantly decreased the tumor size in the high dosage group, compared to control group.

ExcerptRelevanceReference
"5% emulsion, with a dosage of 200 mg/m2 for intrapleural injection once every week for 1-2 weeks and 300-400 mg/m2 for intraperitoneal injection once or twice every week for 2 weeks."( [Phase III clinical trial of elemenum emulsion in the management of malignant pleural and peritoneal effusions].
Sun, Y; Wang, J; Zhang, H, 1996
)
0.29
" The total dosage of 6-12 g was given in 2-6 therapeutic courses with an interval of 1-1."( [Clinical study on treatment of 40 cases of malignant brain tumor by elemene emulsion injection].
Cai, W; Tan, P; Zhong, W, 2000
)
0.54
" A significant suppression of tumor growth was observed when the dosage was increased."( [Inhibition of eIF families expression and angiogenesis for human laryngeal carcinoma by elemene administration].
Tao, L; Yao, M; Zheng, LY; Zhou, L, 2005
)
0.55
" Forty-eight nude mice were subcutaneously xenograft with BxPC-3 pancreatic cancer cells and divided into four groups: Control group and high, medium, low dosage of elemene (20, 40 and 60 mg/kg) treatment groups."( Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
Hui, L; Liu, Z; Long, J, 2019
)
0.97
" The in vivo BxPC-3 xenografts study exhibited that elemene was significantly decreased the tumor size in the high dosage group, compared to control group."( Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
Hui, L; Liu, Z; Long, J, 2019
)
1.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (100)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (3.00)18.7374
1990's4 (4.00)18.2507
2000's23 (23.00)29.6817
2010's45 (45.00)24.3611
2020's25 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.65 (24.57)
Research Supply Index4.62 (2.92)
Research Growth Index5.22 (4.65)
Search Engine Demand Index61.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.00%)5.53%
Reviews20 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other79 (79.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]